OrbiMed Advisors »

Avalo Therapeutics Ord shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.2M 967k 9.50

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Enliven Therapeutics (ELVN)
Biogen Idec (BIIB)
Merck & Co (MRK)
Tenet Healthcare Corp Com New (THC)
Sarepta Therapeutics (SRPT)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)
Argenx Se Sponsored Adr (ARGX)
UnitedHealth (UNH)
Q32 Bio (QTTB)

View all positions for OrbiMed Advisors

Top funds holding Avalo Therapeutics Ord

Ikarian Capital
OrbiMed Advisors
RA Capital Management
BVF
Logos Global Management
Commodore Capital
Sio Capital Management
Affinity Asset Advisors
Vanguard Group
Geode Capital Management
Bank of America Corporation
BlackRock
BlackRock
Morgan Stanley
Efficient Wealth Management

View all funds holding Avalo Therapeutics Ord